180 related articles for article (PubMed ID: 38464749)
1. Identification and validation of shared gene signature of kidney renal clear cell carcinoma and COVID-19.
Nie J; Yang H; Liu X; Deng W; Fu B
PeerJ; 2024; 12():e16927. PubMed ID: 38464749
[TBL] [Abstract][Full Text] [Related]
2. A Novel Prognostic Signature for Survival Prediction and Immune Implication Based on SARS-CoV-2-Related Genes in Kidney Renal Clear Cell Carcinoma.
Huang Y; Chen S; Xiao L; Qin W; Li L; Wang Y; Ma L; Yuan X
Front Bioeng Biotechnol; 2021; 9():744659. PubMed ID: 35141213
[TBL] [Abstract][Full Text] [Related]
3. A novel prognostic signature of chemokines for survival and immune infiltration in kidney renal clear cell carcinoma.
Weng J; Huang Z; Li Q; Huang Y; Chen S
Int J Med Sci; 2023; 20(8):1046-1059. PubMed ID: 37484803
[No Abstract] [Full Text] [Related]
4. Construction and validation of an autophagy-related long noncoding RNA signature for prognosis prediction in kidney renal clear cell carcinoma patients.
Yu J; Mao W; Xu B; Chen M
Cancer Med; 2021 Apr; 10(7):2359-2369. PubMed ID: 33650306
[TBL] [Abstract][Full Text] [Related]
5. Identification of berberine as a potential therapeutic strategy for kidney clear cell carcinoma and COVID-19 based on analysis of large-scale datasets.
Zheng Z; Li X; Nie K; Wang X; Liang W; Yang F; Zheng K; Zheng Y
Front Immunol; 2023; 14():1038651. PubMed ID: 37033923
[TBL] [Abstract][Full Text] [Related]
6. Deciphering key genes involved in cisplatin resistance in kidney renal clear cell carcinoma through a combined
Malik M; Maqbool M; Nisar T; Akhter T; Ujan JA; Algarni AS; Joufi FAA; Alanazi SSK; Almotared MH; Bekhit MMS; Jamil M
Oncol Res; 2023; 31(6):899-916. PubMed ID: 37744271
[TBL] [Abstract][Full Text] [Related]
7. The promising novel biomarkers and candidate small molecule drugs in kidney renal clear cell carcinoma: Evidence from bioinformatics analysis of high-throughput data.
Zhang B; Wu Q; Wang Z; Xu R; Hu X; Sun Y; Wang Q; Ju F; Ren S; Zhang C; Qin L; Ma Q; Zhou YL
Mol Genet Genomic Med; 2019 May; 7(5):e607. PubMed ID: 30793530
[TBL] [Abstract][Full Text] [Related]
8. Low expression of SLC34A1 is associated with poor prognosis in clear cell renal cell carcinoma.
Qiu J; Wang Z; Xu Y; Zhao L; Zhang P; Gao H; Wang Q; Xia Q
BMC Urol; 2023 Mar; 23(1):45. PubMed ID: 36978048
[TBL] [Abstract][Full Text] [Related]
9. Identification of small molecule drugs and development of a novel autophagy-related prognostic signature for kidney renal clear cell carcinoma.
Xing Q; Ji C; Zhu B; Cong R; Wang Y
Cancer Med; 2020 Oct; 9(19):7034-7051. PubMed ID: 32780567
[TBL] [Abstract][Full Text] [Related]
10. Screening Novel Drug Candidates for Kidney Renal Clear Cell Carcinoma Treatment: A Study on Differentially Expressed Genes through the Connectivity Map Database.
Gao B; Wang L; Zhang N; Han M; Zhang Y; Liu H; Sun D; Liu Y
Kidney Blood Press Res; 2021; 46(6):702-713. PubMed ID: 34818247
[TBL] [Abstract][Full Text] [Related]
11. A 9-gene prognostic signature for kidney renal clear cell carcinoma overall survival based on co-expression and regression analyses.
Zhu W; Ding M; Chang J; Liao H; Xiao G; Wang Q
Chem Biol Drug Des; 2023 Feb; 101(2):422-437. PubMed ID: 36053927
[TBL] [Abstract][Full Text] [Related]
12. Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma.
Song J; Liu YD; Su J; Yuan D; Sun F; Zhu J
J Cell Physiol; 2019 Dec; 234(12):22753-22764. PubMed ID: 31140607
[TBL] [Abstract][Full Text] [Related]
13. CD72, a new immune checkpoint molecule, is a novel prognostic biomarker for kidney renal clear cell carcinoma.
Tian L; Wang Y; Zhang Z; Feng X; Xiao F; Zong M
Eur J Med Res; 2023 Nov; 28(1):531. PubMed ID: 37980541
[TBL] [Abstract][Full Text] [Related]
14. Identifying and validating MMP family members (MMP2, MMP9, MMP12, and MMP16) as therapeutic targets and biomarkers in kidney renal clear cell carcinoma (KIRC).
Li K; Li D; Hafez B; Bekhit MMS; Jardan YAB; Alanazi FK; Taha EI; Auda SH; Ramzan F; Jamil M
Oncol Res; 2024; 32(4):737-752. PubMed ID: 38560573
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of MFN2 as a prognostic biomarker associated with immune cell infiltration in renal clear cell carcinoma.
Cheng L; Wang Z; Nie L; Yang C; Huang H; Lin J; Zhuo D
Int Immunopharmacol; 2022 Oct; 111():109169. PubMed ID: 36007389
[TBL] [Abstract][Full Text] [Related]
16. Cuproptosis-Related 4-Gene Risk Model for Predicting Immunotherapy Drug Response and Prognosis of Kidney Renal Clear Cell Carcinoma.
Guo JS; Ding H; Wu PY; Xin ZY; Li JX; Jo HS; Ma ZH
Chin Med Sci J; 2023 Sep; 38(3):191-205. PubMed ID: 37503721
[TBL] [Abstract][Full Text] [Related]
17. Identification and validation of a two-gene metabolic signature for survival prediction in patients with kidney renal clear cell carcinoma.
Guo X; Sun Z; Jiang S; Jin X; Wang H
Aging (Albany NY); 2021 Mar; 13(6):8276-8289. PubMed ID: 33686951
[TBL] [Abstract][Full Text] [Related]
18. Selection of M7G-related lncRNAs in kidney renal clear cell carcinoma and their putative diagnostic and prognostic role.
Zhong S; Chen S; Lin H; Luo Y; He J
BMC Urol; 2023 Nov; 23(1):186. PubMed ID: 37968670
[TBL] [Abstract][Full Text] [Related]
19. A seven-gene signature model predicts overall survival in kidney renal clear cell carcinoma.
Chen L; Xiang Z; Chen X; Zhu X; Peng X
Hereditas; 2020 Sep; 157(1):38. PubMed ID: 32883362
[TBL] [Abstract][Full Text] [Related]
20. Immune associated LncRNAs identify novel prognostic subtypes of renal clear cell carcinoma.
Khadirnaikar S; Kumar P; Pandi SN; Malik R; Dhanasekaran SM; Shukla SK
Mol Carcinog; 2019 Apr; 58(4):544-553. PubMed ID: 30520148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
